Germline mutations in BAP1 predispose to melanocytic tumors

Thomas Wiesner, Michael R. Speicher(Medical University of Graz), Shea Loy(Memorial Sloan Kettering Cancer Center), Ingrid Wolf(Medical University of Graz), Klaus Griewank(Düsseldorf University Hospital), Peter Ulz(Freenome (United States)), Werner Wackernagel(Medical University of Graz), Arno Rütten(Dermatopathologie Friedrichshafen), Nicholas D. Socci, David H. Abramson(Memorial Sloan Kettering Cancer Center), Arthur Ott(Medical University of Graz), Christian Windpassinger(Medical University of Graz), Rajmohan Murali(Memorial Sloan Kettering Cancer Center), Boris C. Bastian(University of California, San Francisco), Agnès Viale(Genomics (United Kingdom)), Jürgen C. Becker(Düsseldorf University Hospital), Alex Lash(Memorial Sloan Kettering Cancer Center), Lorenzo Cerroni(Medical University of Graz), Anna C. Obenauf(Research Institute of Molecular Pathology), Heinz Kutzner(Dermatopathologie Friedrichshafen), Isabella Fried(Medical University of Graz), Mono Pirun(Memorial Sloan Kettering Cancer Center), Gabriele Palmedo(Dermatopathologie Friedrichshafen), Kenneth Offit(Memorial Sloan Kettering Cancer Center)
Nature Genetics
August 28, 2011
Cited by 724


Related Papers